Skip to main content
logo
Oncoinvent ASA (OSL:ONCIN)
Norway flag Norway · Delayed Price · Currency is NOK
141.00
+6.50 (4.83%)
Sep 14, 2026, 1:10 PM CET

Oncoinvent ASA Financials Overview

Millions NOK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
24.3128.078.15.796.2811.08
Revenue Growth
-13.38%246.40%39.95%-7.85%-43.31%6.80%
Gross Profit
24.3128.078.15.796.2810.19
Operating Income
-175.31-158.33-141.02-147.43-110.61-80.83
Net Income
-171.16-155.07-140.2-143.62-106.28-80.29
Earnings Per Share
-57.11-125.13-561.04-738.62-548.04-404.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
106.77177.6133.6730.1196.02292.03
Total Debt
2.043.557.4512.1712.03-
Net Cash (Debt)
104.74174.05126.2217.92183.99292.03
Net Cash Growth
-39.82%37.90%604.25%-90.26%-37.00%157.76%
Net Cash Per Share
34.95140.45505.0792.17948.731469.46

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-132.58-129.87-87.94-138.11-89.19-
Capital Expenditures
-0.15-0.12-1.8-26.83-3.98-
Free Cash Flow
-132.74-129.99-89.75-164.94-93.17-
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%91.92%
Operating Margin
-721.06%-564.07%-1740.31%-2546.20%-1760.48%-729.27%
Pretax Margin
-704.00%-552.46%-1730.24%-2480.50%-1691.55%-724.43%
Profit Margin
-704.00%-552.46%-1730.24%-2480.50%-1691.55%-724.43%
FCF Margin
-545.98%-463.11%-1107.55%-2848.72%-1482.94%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
24.787.83----